Operation Game- A Patient’s Journey Through HeFH: Diagnosis and Management

Target Audience
This activity has been designed to address the educational needs of cardiologists, cardiology nurses, lipid specialists, and primary care clinicians, including internists, pharmacists, nurses, nurse practitioners, PAs, and dietitians. It may also benefit other healthcare providers who manage patients with hypercholesterolemia.

Program Overview
Nonstatins are an essential therapy for lowering low-density lipoprotein cholesterol (LDL-C) levels in high-risk patients, such as those with heterozygous familial hypercholesterolemia (HeFH). Join Dr Soffer as he explores HeFH through this engaging drag-and-drop game of Operation.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Distinguish among the unique drug characteristics of newer and emerging nonstatin LDL-C therapies that may impact clinical decision-making
Formulate evidence-based treatment plans for patients who require additional LDL-C lowering beyond statin therapy, while engaging in shared decision-making to facilitate adherence